Heron Therapeutics Inc

XNAS:HRTX 4:00:00 PM EDT

0.33

-0.02 (-4.86%)

: $0.33 0.00 (-0.90%)

Market Cap (Intraday)	63.22M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$37.5 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	$0.33
50-Day MA	$0.40
200-Day MA	$0.87

See more pivots

Heron Therapeutics Inc Stock, XNAS:HRTX

100 Regency Forest Drive, Suite 300, Cary, North Carolina 27518

United States of America

Phone: +1.858.251.4400

Number of Employees: 122

http://www.herontx.com

Description

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.